相关实验视频
Updated: Jul 24, 2025

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.5K
一个circRNA-miRNA-mRNA网络分析人类心力衰竭的潜在病原体
Ran Xu1, Jian Wu1, Chun-Jie Yang1
1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Journal of geriatric cardiology : JGC
|July 3, 2023
概括
循环RNAs (circRNAs) 在心脏中表现出不同的表达模式,并参与心力衰竭 (HF) 病变发生. 这项研究确定了关键的circRNA及其调节网络,为HF分子机制提供了洞察力.
科学领域:
- 心血管生物学 心血管生物学
- 分子遗传学 分子遗传学
- 非编码RNA研究研究
背景情况:
- 心力衰竭 (HF) 的分子机制仍然不完全理解.
- 循环RNAs (circRNAs) 在心脏组织中越来越多地被识别出来.
- 这项研究调查了circRNAs在HF中的潜在作用.
研究的目的:
- 为了描述心脏中的circRNA表达.
- 在HF中识别差异表达的circRNAs (DECs).
- 探索HF中的circRNA-miRNA调节网络.
主要方法:
- 进行RNA测序以分析心脏circRNAs.
- 生物信息分析用于识别DEC和宿主基因.
- 基因本体学分析用于途径丰富.
- 构建一个circRNA-miRNA相互作用网络.
主要成果:
- 大多数心脏circRNA是<2000nt;染色体1拥有最多,Y染色体拥有最少.
- 确定了238个DEC和203个宿主基因;只有4个宿主基因与已知的HF DEG重叠.
- 丰富的途径包括免疫系统,新陈代谢和信号传导;确定了1052个向的miRNAs.
- 构建了一个circRNA-miRNA网络,揭示了复杂的调节相互作用.
结论:
- 循环RNAs表现出物种和组织特定的表达.
- 循环RNA表达独立于宿主基因,但DEC和DEG在HF中共享功能途径.
- 这些发现促进了对circRNAs在HF中的作用的理解,并为未来的研究提供了基础.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure I: Introduction
20
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
20
Pathophysiology of Cardiac Performance
708
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
708
Coronary Artery Disease II: Pathophysiology
14
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
14
Mitral Regurgitation I: Introduction
18
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
18

